You are here: Industry Insights > NHS

News List

First UK healthcare worker to enrol in COVID-19 prevention trial pharmatimes
May 21, 2020
The first UK frontline NHS worker will today enrol in a new study designed to test the potential of hydroxychloroquine to prevent infection with novel coronavirus.
NHS England confirms four new ICSs pharmatimes
May 13, 2020
NHS England has confirmed four new integrated care systems (ICS) in England, joining the 14 already in existence plus two devolved health systems in Greater Manchester and Surrey.
New partnership to sequence human genomes in fight against coronavirus pharmatimes
May 13, 2020
As of this morning – Wednesday May 13 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 226,463 with 32,692 deaths.
PM faces calls for inquiry into BAME COVID-19 death risk pharmatimes
May 12, 2020
Campaigners are urging the government to investigate the disproportionate impact of coronavirus on people with black, Asian and minority ethnic (BAME) backgrounds.
ICR welcomes new advanced prostate cancer treatment guideline pharmatimes
May 08, 2020
The Institute of Cancer Research, London, has welcomed approval of targeted hormone therapies enzalutamide and abiraterone as first-line NHS treatments for men with advanced prostate cancer.
Imperial College London partners with NHS Trust to make PPE pharmatimes
May 07, 2020
As of this morning – Thursday May 7 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 201,101 with 30,076 deaths.
NICE backs NHS use of Bayer's Vitrakvi via the CDF pharmatimes
April 26, 2020
Bayer's Vitrakvi (larotrectinib) will be available via the NHS in England and Wales to treat a variety of cancers.
SMC accepts Janssen’s ulcerative colitis drug Stelara for NHS use pharmaceutical-technology
April 17, 2020
Scottish Medicines Consortium (SMC) has accepted Janssen Pharmaceutical’s Stelara (ustekinumab) for use on the National Health Service (NHS) Scotland to treat moderately to severely active ulcerative colitis (UC) in adults.
Gov't streams £14bn into public services in COVID-19 response pharmatimes
April 15, 2020
More than £14 billion from the Coronavirus emergency response fund will be streamed into public services.
SMC accepts four medicines for NHS use pharmatimes
April 15, 2020
Biogen’s Fampyra (fampridine) has become the first treatment funded by NHS Scotland to improve walking difficulties in adult patients with all types of multiple sclerosis (MS).

Previous page 1 2 3 4 5 6 7 8 9 10 ... 44 45 Next page